HORNBILL: A First-in-Human Phase I/IIa Study of the Safety, Tolerability and Early Pharmacodynamics of BI 764524 for Diabetic Macular Ischemia

DOI: 10.1016/j.xops.2025.100781 Publication Date: 2025-04-01T09:45:34Z